10147-69-0

Basic information

• Product Name: 2-CHLORO-N-(3-HYDROXY-PHENYL)-ACETAMIDE
• Synonyms: 2-CHLORO-N-(3-HYDROXY-PHENYL)-ACETAMIDE;2'-CHLORO-3-HYDROXYACETANILIDE;2-chloro-N-(3-hydroxyphenyl)ethanamide;Acetamide, 2-chloro-N-(3-hydroxyphenyl)-
• CAS NO: 10147-69-0
• Molecular Formula: C₈H₈ClNO₂
• Molecular Weight: 185.61
• Mol File: 10147-69-0.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 414.4 °C at 760 mmHg
• Flash Point: 204.4 °C
• Appearance: /
• Density: 1.402 g/cm³
• Vapor Pressure: 1.86E-07mmHg at 25°C
• Refractive Index: 1.632
• CAS DataBase Reference: 2-CHLORO-N-(3-HYDROXY-PHENYL)-ACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLORO-N-(3-HYDROXY-PHENYL)-ACETAMIDE(10147-69-0)
• EPA Substance Registry System: 2-CHLORO-N-(3-HYDROXY-PHENYL)-ACETAMIDE(10147-69-0)

Safety Data

• Hazardous Substances Data: 10147-69-0(Hazardous Substances Data)

Usage

General Description

2-CHLORO-N-(3-HYDROXY-PHENYL)-ACETAMIDE, also known as chlorzoxazone, is a chemical compound with the molecular formula C7H7ClN2O2. It is a centrally-acting muscle relaxant that works by inhibiting the release of muscle excitation-contraction coupling, which leads to muscle relaxation. Chlorzoxazone is primarily used to relieve muscle spasms and discomfort caused by injuries, but it is also used in the treatment of conditions such as cerebral palsy, multiple sclerosis, and stroke. It is available in oral tablet form and is generally well-tolerated, although it may cause drowsiness, dizziness, or nausea as side effects. Overall, 2-CHLORO-N-(3-HYDROXY-PHENYL)-ACETAMIDE is an important pharmaceutical chemical for managing muscle-related conditions.

InChI:InChI=1/C8H8ClNO2/c9-5-8(12)10-6-2-1-3-7(11)4-6/h1-4,11H,5H2,(H,10,12)

Upstream product

• 591-27-5 m-Hydroxyaniline 
• 541-88-8 Chloroacetic anhydride 
• 79-04-9 chloroacetyl chloride 

Downstream Products

• 51964-26-2 3-(3-hydroxy-phenyl)-thiazolidine-2,4-dione 
• 1182347-19-8 diethyl [N-(3-hydroxyphenyl)carbamoyl]methylphosphonate 
• 916337-42-3 C₁₀H₁₂ClNO₃ 

Relevant articles and documents

Thiazolidine-2,4-dione-based irreversible allosteric IKK-β kinase inhibitors: Optimization into in vivo active anti-inflammatory agents

Selective kinase inhibitors development is a cumbersome task because of ATP binding sites similarities across kinases. On contrast, irreversible allosteric covalent inhibition offers opportunity to develop novel selective kinase inhibitors. Previously, we

A highly selective and sensitive fluorescent chemosensor for Fe 3+ in physiological aqueous solution

A novel fluorescent chemosensor in which two aza-18-crown-6 moieties are linked to a coumarin fluorophore has been synthesized for sensing Fe 3+. The selective fluorescence enhancement was observed upon binding Fe3+ at physiological

Antidiabetic compounds

Compounds for the treatment of hyperglycemia and/or diabetes are provided. The compounds, which inhibit the enzyme dipeptidyl peptidase (DPP-4), are based on the structure where X may be present or absent an may be OH, Ar is an aryl group; and n ranges from 0 to 5.